[1] Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz’s disease and sclerosing pancreatitis: diagnostic insights [J]. J Rheumatol, 2010, 37(7): 1380-1385. [2] Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease [J]. Mod Pathol, 2012, 25(9): 1181-1192. [3] Geyer JT, Deshpande V. IgG4-associated sialadenitis [J]. Curr Opin Rheumatol, 2011, 23(1): 95-101. [4] Takahashi H, Yamamoto M, Shinomura Y, et al. Long-term outcomes and necessity of early intervention for IgG4-related disease [J]. Nihon Rinsho Meneki Gakkai Kaishi, 2013, 36(6): 442-451. [5] Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002, 61(6): 554-558. [6] Wang ZJ, Zheng LY, Pu YP, et al. Clinical features and treatment outcomes of immunoglobulin G4-related sclerosing sialadenitis[J]. J Craniofac Surg, 2014, 25(6): 2089-2093. [7] 王知俊, 俞创奇, 郑凌艳, 等. IgG4相关唾液腺炎临床诊疗特点[J]. 口腔颌面外科杂志, 2013, 23(6): 432-437. [8] Bamba R, Sweiss NJ, Langerman AJ, et al. The minor salivary gland biopsy as a diagnostic tool for Sjögren syndrome [J]. Laryngoscope, 2009, 119(10): 1922-1926. [9] Takano K, Yamamoto M, Takahashi H, et al. Clinicopathologic similarities between Mikulicz's disease and Küttner tumor [J]. Am J Otolaryngol, 2010, 31(6): 429-434. [10] Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz's disease and Sjögren’s syndrome [J]. Rheumatology (Oxford), 2005, 44(2): 227-234. [11] Moriyama M, Tanaka A, Maehara T, et al. Clinical characteristics of Mikulicz's disease as an IgG4-related disease[J]. Clin Oral Investig, 2013, 17(9): 1995-2002. [12] Takahashi H, Yamamoto M, Tabeya T, et al. The immunobiology and clinical characteristics of IgG4 related diseases[J]. J Autoimmun, 2012, 39(1-2): 93-96. |